SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
Advertisement

SAB Biotherapeutics (SABS) Technical Analysis

Compare
179 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
SAB Biotherapeutics’s (SABS) Moving Averages Convergence Divergence (MACD) indicator is 0.20, suggesting SAB Biotherapeutics is a Buy.
SAB Biotherapeutics’s (SABS) 20-Day exponential moving average is 3.05, while SAB Biotherapeutics’s (SABS) share price is $3.24, making it a Buy.
SAB Biotherapeutics’s (SABS) 50-Day exponential moving average is 2.73, while SAB Biotherapeutics’s (SABS) share price is $3.24, making it a Buy.

SAB Biotherapeutics (SABS) Pivot Points

Nov 16, 2025, 09:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.41
2.75
2.92
3.26
3.43
3.77
3.94
Fibonacci
2.75
2.94
3.06
3.26
3.45
3.57
3.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SAB Biotherapeutics (SABS) Moving Averages

Nov 16, 2025, 09:42 AM
Period
Simple
Exponential
MA5
3.24Sell
3.22Buy
MA10
3.22Buy
3.19Buy
MA20
3.13Buy
3.05Buy
MA50
2.59Buy
2.73Buy
MA100
2.42Buy
2.51Buy
MA200
2.05Buy
2.43Buy
SAB Biotherapeutics’s (SABS) 10-Day exponential moving average is 3.19, while SAB Biotherapeutics’s (SABS) share price is $3.24, making it a Buy.
SAB Biotherapeutics’s (SABS) 100-Day exponential moving average is 2.51, while SAB Biotherapeutics’s (SABS) share price is $3.24, making it a Buy.
SAB Biotherapeutics’s (SABS) stock price is $3.24 and SAB Biotherapeutics’s (SABS) 50-day simple moving average is 2.59, creating a Buy signal.
SAB Biotherapeutics’s (SABS) stock price is $3.24 and SAB Biotherapeutics’s (SABS) 100-day simple moving average is 2.42, creating a Buy signal.
SAB Biotherapeutics’s (SABS) stock price is $3.24 and SAB Biotherapeutics’s (SABS) 200-day simple moving average is 2.05, creating a Buy signal.

SAB Biotherapeutics (SABS) Technical Indicators

Nov 16, 2025, 09:42 AM
Name
Value
Implied Action
RSI (14)
60.57
Neutral
STOCH (9,6)
60.93
Neutral
STOCHRSI (14)
60.93
Neutral
MACD (12,26)
0.20
Buy
ADX (14)
34.66
Neutral
Williams %R
-46.72
Buy
CCI (14)
46.44
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
61.25
Neutral
ROC
6.93
Buy
SAB Biotherapeutics’s (SABS) Relative Strength Index (RSI) is 60.57, creating a Neutral signal.
SAB Biotherapeutics’s (SABS) Trend Strength Indicator (ADX) is 34.66, creating a Neutral signal.
SAB Biotherapeutics’s (SABS) Commodity Channel Index (CCI) is 46.44, creating a Neutral signal.
SAB Biotherapeutics’s (SABS) Price Rate of Change (ROC) is 6.93, creating a Buy signal.

FAQ

Is SABS a Buy, Hold, or Sell?
Based on SABS’s technical indicators, SABS is a Strong Buy.
    What is SABS’s RSI (14)?
    SABS’s RSI (14) is 60.57, which suggests SABS is a Neutral.
      What is SABS’s MACD?
      SABS’s MACD is 0.20, which suggests SABS is a Buy.
        What is SABS’s 5-day moving average?
        SABS’s 5-day moving average is 3.24, which suggests SABS is a Sell.
          What is SABS’s 20-day moving average?
          SABS 20-day moving average is 3.13, which suggests SABS is a Buy.
            What is SABS’s 50-day moving average?
            SABS’s 50-day moving average is 2.59, which suggests SABS is a Buy.
              What is SABS’s 200-day moving average?
              SABS’s 200-day moving average is 2.05, which suggests SABS is a Buy.
                What is SABS’s Williams % R (14)?
                SABS’s Williams % R (14) is -46.72, which suggests SABS is a Buy.
                  What is SABS’s CCI (14)?
                  SABS’s CCI (14) is 46.44, which suggests SABS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis